The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21.10 - Manufacture of basic pharmaceutical products
120 jobs Number of planned job creations
Announcement Date
29 January 2023
Employment effect (start)
1 March 2023
Foreseen end date
30 September 2024
Description
Pharmaceutical company Lek from Ljubljana, part of the Swiss-based Sandoz group (Novartis), announced an €83 million investment in the Ljubljana plant and the creation of around 120 jobs.
The new liquid vial and pre-filled syringe manufacturing facility will be completed in October 2024. In February 2023, the government confirmed the subsidy of €6.56 million for the investment.
Novartis intends to spin off the Sandoz division to be sold. Slovenian company Lek is officially part of Sandoz division but produces for both Sandoz and Novartis. It has already been decided that Lek will be divided as well. The units in Ljubljana and Mengeš will be integrated into Novartis, plants in Prevalje and Lendava will stay with Sandoz.
According to the Sloexport database, Lek currently employ 4797 workers.
Eurofound (2023), Lek, Business expansion in Slovenia, factsheet number 108432, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/108432.